Home
Search
Schedule & Agenda

Company Presentations-Thursday Block

10:30 AM - 1:00 PM (EDT), Thursday, June 8, 2023 ・ Session Rooms 103-104C
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1 in Rooms 103, 104A, 104B, and 104C all four days of Convention.

Company Presentations are accessible to all registered attendees.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Not Provided
Company HQ State:
Not Provided
Company HQ Country:
Not Provided
Year Founded:
Not Provided
Main Therapeutic Focus:
Not Provided
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
10:30 AM - 10:45 AM
Covant Therapeutics
Covant’s mission is to treat diseases with transformative therapeutics using covalency to modulate…
Session Room 104A
Modulus Discovery, Inc.
Modulus Discovery, Inc., is a pre-clinical stage biotechnology company with a cutting-edge…
Session Room 103
10:45 AM - 11:00 AM
Sarcomatrix Therapeutics Corp.
Sarcomatrix is a pre-clinical biotech developing first-in-class drugs to treat muscle wasting…
Session Room 104A
Ethris
Ethris mission is to redefine mRNA medicines through best-in-industry delivery, stability,and…
Session Room 103
11:00 AM - 11:15 AM
ITabMed
ITabMed Ltd. is a clinical-stage biotech company developing immunotherapy antibodies (ITAbTM) to…
Session Room 103
Novelna Inc.
Novelna Inc. is a biotech start-up, pioneering accurate and affordable screening tests for early…
Session Room 104A
11:15 AM - 11:30 AM
KaliVir Immunotherapeutics, Inc.
KaliVir Immunotherapeutics is a private biotechnology company dedicated to developing systemically…
Session Room 103
Cyrus Biotechnology
Cyrus Biotechnology is a pre-clinical-stage biotech company combining computational protein …
Session Room 104A
11:30 AM - 11:45 AM
PeptiDream Inc.
PeptiDream Inc. (Tokyo Stock Exchange: 4587) is leading the translation of macrocyclic peptides…
Session Room 104A
Phanes Therapeutics, Inc.
Phanes is a clinical stage biotech focused on innovative drug discovery and development in oncology…
Session Room 103
11:45 AM - 12:00 PM
XtalPi
Founded in 2014, XtalPi founders recognized a common hurdle in drug development having to do with…
Session Room 103
NRx Pharmaceuticals, Inc.
Clinical-stage biopharmaceutical company developing therapeutics for the treatment of central…
Session Room 104A
12:00 PM - 12:15 PM
FivepHusion
FivepHusion is an advanced clinical stage biotech company developing Deflexifol™, a novel enhanced…
Session Room 103
12:15 PM - 12:30 PM
Basgenbio Inc.
Basgenbio is a clinico-genomic cohort-based R&D company with K-Biobank, which contains blood…
Session Room 103
12:15 PM - 1:00 PM
Protibea Therapeutics Inc.
Protibea is a clinical stage company whose product has been dosed in 200+ patients for up to one…
Session Room 104A
12:30 PM - 12:45 PM
Henlius Biotech
Henlius is a global biopharmaceutical company with the vision to offer high-quality, affordable,…
Session Room 103
Precision NanoSystems
Precision NanoSystems, now part of the Danaher Life Sciences platform, is a global leader in…
Session Room 104A
12:45 PM - 1:00 PM
Etern Bio
Co-founded by Professor Junying Yuan and Professor Jidong Zhu, two leading scientists in cell death…
Session Room 103
TiCARos
TiCARos is developing very differentiated CAR-T based on our proprietary CAR-T construct designing…
Session Room 104A
3:00 PM - 3:15 PM
Affivant
Affivant is a Basel, Switzerland based biotech company developing innate immune cell engagers for…
Session Room 104B
4:45 PM - 5:00 PM
Accession Therapeutics
Accession Therapeutics is developing a new generation of immunotherapies for solid tumors. …
Session Room 104B
Load More